Canadians Facing Delayed Access to New, Innovative Medicines: Report

Tuesday, May 24, 2016 Lifestyle News
Email Print This Page Comment bookmark
Font : A-A+

OTTAWA, May 24, 2016 /CNW/ - Canadians face wait times of about 449 days in order to get access to new, potentially lifesaving

medicines in public drug plans, according to a new IMS Health Canada Inc. report commissioned by Innovative Medicines Canada.

The 2016 Access to New Medicines in Public Drug Plans: Canada and Comparable Countries

analyzed reimbursement for new medicines in provincial drug plans comprising at least 80% of the eligible national drug plan population. The report finds Canada's public drug plans are seriously lagging compared to other similar OECD nations.

Canadians who rely on public drug plans are facing more than a year's delay to access new, potentially lifesaving treatments. This report shines the light on why access to medicines in Canada needs to be improved – patients must come first.

QUICK FACTS

  • In Canada, 59% of cancer medicines were covered in public drug plans, ranking Canada in 17th place of 20 countries.
  • Canadian public drug plans placed reimbursement conditions on 90% of new medicines, ranking Canada 17th of 20 countries.
  • In Canada, only 23% of new biologic medicines were reimbursed in public drug plans, putting Canada in 19th place of 20 countries.

QUOTES

"Compared to similar countries, Canadian patients have access to fewer new medicines and also face long delays for the drugs that are covered under public drug plans." – Brett Skinner, Executive Director, Health and Economic Policy, Innovative Medicines Canada

"Canada needs to get these life-altering innovations to patients faster and without delay – no excuses, just do it." – Larry Taylor, living with diabetes

ABOUT INNOVATIVE MEDICINES CANADA

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.

 

SOURCE Innovative Medicines Canada



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook